The way I look at our pps is as follows:
1. Based on what we have and/or what we know at this current point in time, we are SEVERELY UNDERVALUED.
2. Prior to the first major PR (Patent for MS back in January 2021), we were trading around .116. Considering that MS patent, along with...
- HIV Patent
- China-Virus Patent
- INTEL Collaboration / AI
- Samsung Partnership
- Immune Modulator Sales in NA + NPI
- ITV1 Coming in Africa
- + all others I've left out....
the pps of .079 is an absolute joke, and undervalued beyond any logical thought. Just the HIV & China Virus patents alone, put this value easily 10X higher than where we currently sit. Think about it for a minute, any pharma who wants to use the conserved sites on either virus, will be required to do so through ENZC. And we're supposed to believe a market cap of only $221M is legit? I don't buy it.
That said, I believe that the lack of audited fins (Not officially SEC Fully Reporting Co., so main risk still lingering) coupled with the twat nonsense/pulling football away of Tom & Chandra (#MarchToRemember, #MarchIsntOverYet Huge Announcements Coming, #Equity, etc...), are the reason why retail volume is not pouring in. As long as it stays this way (sitting on fence), we can be easily held with little to no risk at all to those holding it... Also, as long as STXG/large seller is visible on L2, those holding it are more than likely confident that they'll be able to cover/acquire any shares they're forced to print to keep it down...
One of these days we will get back to a fair/accurate valuation, but not before Charles lets go of the audit or before they actually drop "HUGE" news...
$ENZC
News 
Market Data 
Discover 
